July 26, 2016 2:48 PM ET

Healthcare Providers and Services

Company Overview of Enzo Clinical Labs, Inc.

Company Overview

Enzo Clinical Labs, Inc. operates clinical reference laboratories in the United States. It offers various assays in the areas of chemistry, fertility and hormone studies, pregnancy, hematology, and coagulation. The company also provides electronic report delivery services for physicians. In addition, it offers phlebotomy services for patients needing blood tests through its network of patient service centers; diagnostic test that assists in risk assessment and early detection of lung cancer; and ColonSentry, a blood test to assess an individual's current risk for colorectal cancer. Enzo Clinical Labs, Inc. is based in Farmingdale, New York. The company has patient service centers in Manhatta...

60 Executive Boulevard

Farmingdale, NY 11735

United States

Phone:

631-755-5500

Fax:

631-755-5561

Key Executives for Enzo Clinical Labs, Inc.

Chairman of the Board and Chief Executive Officer
Age: 73
President of Enzo Biochem Inc
Age: 66
Scientific Director and Associate Medical Director
Compensation as of Fiscal Year 2016.

Enzo Clinical Labs, Inc. Key Developments

Enzo Clinical Labs, Inc. Reports Unaudited Earnings Results for the First Quarter Ended October 31, 2015

Enzo Clinical Labs, Inc. reported unaudited earnings results for the first quarter ended October 31, 2015. For the quarter, the company reported revenues of $17.1 million, an increase of $1.3 million or 8%, over prior year of $15.9 million, due to the continued focus on its menu of high margin molecular-based assays. Operating profit advanced to $0.8 million, from just above break-even last year.

Enzo Clinical Labs Announces Unaudited Earnings Results for the Third Quarter Ended April 30, 2015

Enzo Clinical Labs announced unaudited earnings results for the third quarter ended April 30, 2015. For the quarter, the company revenues grew to $15.7 million, an 8% increase over the prior year period. Operating income was $0.3 million, a $3.6 million turnaround from a year ago.

Enzo Clinical Labs, Inc. Reports Unaudited Earnings Results for the First Quarter Ended October 31, 2014

Enzo Clinical Labs, Inc. reported unaudited earnings results for the first quarter ended October 31, 2014. For the quarter, the company reported that its results benefited from several factors, including greater emphasis and use of molecular diagnostic testing and increased operating efficiencies from streamlining efforts and recently implemented process and operational enhancements. Revenues increased 6%, to a record $15.8 million. Operating income was essentially breakeven, a $900,000 improvement compared to a year ago operating loss of approximately $0.9 million, and EBITDA was a positive $0.4 million, compared to last year’s negative EBITDA of $0.5 million.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1125 Sir Francis Drake Boulevard Operating Company, Llc United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Enzo Clinical Labs, Inc., please visit www.enzo.com/clinicallabs/index.asp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.